Toripalimab plus anlotinib in patients with recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm phase 2 trial (TORAL)
Autor: | Zhang, Yuchen, Zou, Qihua, Zhao, Baitian, Su, Ning, Li, Zhihua, Wang, Xicheng, Liu, Panpan, Tian, Xiaopeng, Fang, Xiaojie, Cai, Jun, Li, Lirong, Liu, Yingxian, Xia, Yi, Cai, Qingqing |
---|---|
Zdroj: | In Cell Reports Medicine 17 December 2024 5(12) |
Databáze: | ScienceDirect |
Externí odkaz: |